San Francisco, March 10, 2016 -- Deceptive representation of an original food product and pharmaceutical is referred to as counterferfeiting. Increasing growth of low quality and cheap counterfeit products mainly pertaining to the food and pharmaceuticals industries have promoted the rate of implementation of anti-counterfeiting technologies. Trace technologies, covert features enabling and overt/visible feature are some of the key technologies associated with anti-counterfeiting. The U.S FDA stated that, Pharmaceutical manufacturers in the U.S suffer revenue loss of USD 300 billion everywhere .This was mainly due to the counterfeiting in the region. On addition, these products also affect the brand image of the original manufacturer as they achieve low on quality.
Rising awareness levels of regulatory authorities like the U.S FDA coupled with manufacturers’ losses in terms of brand image and revenue is likely to boost the anti-counterfeiting technologies market.
Browse to access In-depth research report on Global Pharmaceuticals And Food Anti-Counterfeiting Technologies Market with detailed charts and figures: http://www.grandviewresearch.com/industry-analysis/pharmaceuticals-and-food-anti-counterfeiting
Abundant existence of untapped opportunities in Asian countries with increased counterfeiting occurrences in china coupled with Augmenting demand for advanced technologies like ultra high RFID tags is expected to boost the industry growth over the coming years. China contributes for over 70% of the total customs seizures according to the report published by World Customs Organization.
In 2012, bar codes segment dominated the worldwide pharmaceutical and food anti-counterfeiting technologies market. Advanced existence of high market penetration rates of this technology in food and drugs industries mainly pertaining to the packaging and inventory management facets displayed by this technology will drive the industry. RFID based technology acts as the driver for the overall market as the technology is relatively cheaper as compared to others.
Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/pharmaceuticals-and-food-anti-counterfeiting/request
In terms of revenue, Pharmaceutical anti-counterfeiting applications dominated the entire market in 2013. It contributed the market share of over USD 40 billion in the year 2012. Increasing adoption rates of anti- counterfeiting in the pharmaceuticals sector is the major factor boosting the market. Furthermore, food counterferfeiting technologies industry is likely to undergo a highest CAGR over the coming years. This is mainly due to rising awareness levels of manufacturers and existence of a constantly advancing infrastructure that support the execution of these technologies
In terms of revenue share, North America dominated the overall market for anti-counterfeiting technologies in the year 2012.Implementation of strict and diligent regulations by the FDA coupled with existence of sophisticated healthcare infrastructure in the region are the factors expected to drive the market further.
Browse related reports by Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-pharmaceuticals-and-food-anti-counterfeiting
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
email: [email protected]
Web: www.grandviewresearch.com


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Instagram Outage Disrupts Thousands of U.S. Users
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



